MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Clinical applications of cortical finely tuned gamma oscillations induced via subthalamic deep brain stimulation in Parkinson’s disease

    M. Shcherbakova, S. Cernera, A. Hahn, S. Little, P. Starr (San Francisco, USA)

    Objective: To investigate the clinical relevance of entraining finely tuned gamma (FTG) oscillations via deep brain stimulation (DBS) in Parkinson’s disease (PD). Background: Prior studies…
  • 2024 International Congress

    Neurophenomenological Aspects of Monocular Visual Hallucinations in Charles Bonnet Syndrome in a patient with Parkinson’s Disease

    D. Nolasco, A. Makarem, B. Buchowicz, L. Schmidt, B. Carr (Gainesville, USA)

    Objective: This inquiry aims to augment understanding of Charles Bonnet Syndrome (CBS) by scrutinizing both monocular and bilateral visual hallucinations. It focuses on an atypical…
  • 2024 International Congress

    Anosognosia for hardware-related complications in deep brain stimulation

    F. Wolff Fernandes, J. Runge, A. Saryyeva, JK. Krauss (Hannover, Germany)

    Objective: In this series, we report two rare cases of selective unawareness to hardware-related complications in deep brain stimulation (DBS). Background: DBS has shown good…
  • 2024 International Congress

    Movement disorders in Brain Sagging Syndrome- A Systematic Review

    A. Datta, A. Lenka (Minneapolis, USA)

    Objective: Objective: This study aims to systematically review the array of movement disorders observed in patients diagnosed with brain sagging syndrome (BSS) secondary to spontaneous…
  • 2024 International Congress

    Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.

    G. Ilina, D. Khasanova, Z. Zalyalova, A. Katok (Kazan, Russian Federation)

    Objective: To study the clinical and neuroimaging features of a patient with a long-term use (more than 10 years) of desomorphine in the anamnesis. Background:…
  • 2024 International Congress

    Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease

    T. Fitzgerald, C. O'Keeffe, J. Inocentes, E. Murphy, M. Bradley, C. Fearon, R. Reilly (Dublin, Ireland)

    Objective: The objective of this study was to determine the most relevant biomechanical factors contributing to the risk of falling in those with Parkinson’s Disease…
  • 2024 International Congress

    Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis

    N. Xia, J. Ripping, R. Bakshi, E. Macklin, S. Molsberry, X. Chen, A. Ascherio, M. Schwarzschild (Charlestown, USA)

    Objective: To explore piperine as a potential biomarker for Parkinson’s disease (PD) among GBA and LRRK2 mutation carriers and non-carriers. Background: Piperine is a yellow…
  • 2024 International Congress

    V-ATPase subunit V1G1 overexpression conferred the mice neuroprotection during MPTP exposure

    YIM. Wang, Y. Li, Y. Xia, L. Kou, T. Wang (武汉市, China)

    Objective: Elucidating the role of lysosomal dysfunction due to altered stability and expression levels of V-type proton ATPase subunit G (V1G1) in the degradation and…
  • 2024 International Congress

    Utility of using long-read whole genome sequencing to solve exome negative early-onset and familial Parkinson’s disease: a series of 106 individuals

    G. Cogan, K. Bilingsley, K. Daida, C. Tesson, T. Courtin, M. Ferrien, A. Singleton, S. Lesage, C. Blauwendraat, A. Brice (Paris, France)

    Objective: (i) To identify complex variants usually not visible by short-read whole exome sequencing in known genes of Parkinson’s disease (PD) such as structural variants…
  • 2024 International Congress

    Distinct patterns of Gene Expression in Skin-biopsy Derived Fibroblasts of Patients with Parkinson’s disease

    T. Ntetsika, I. Markaki, A. Damdimopoulos, M. Zeitelhofer, P. Tsitsi, M. Zeitelhofer Adzemovic, P. Svenningsson (Stockholm, Sweden)

    Objective: In this study, we aimed to investigate global gene expression alterations in cultured skin fibroblasts from individuals with idiopathic Parkinson’s disease (PD) compared to…
  • « Previous Page
  • 1
  • …
  • 300
  • 301
  • 302
  • 303
  • 304
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley